Design, synthesis, and anticonvulsant evaluation of 4-GABA-3-nitrocoumarines, 1-thiocoumarines, quinolone-2-ones, and their derivatives
作者:G. V. Mokrov、S. A. Litvinova、T. A. Voronina、L. N. Nerobkova、I. S. Kutepova、I. G. Kovalev、T. A. Gudasheva、A. D. Durnev
DOI:10.1007/s00044-019-02422-5
日期:2019.11
The novel group of 4-GABA-3-nitrocoumarines, 1-thiocoumarines, quinolone-2-ones, and their derivatives was designed as potential anticonvulsants using GABA pharmacophore and corresponding heterocyclic moieties. A number of compounds of this group were synthesized and studied in the maximum electroshock seizure (MES) test and in the model of primary-generalized convulsions caused by subcutaneous pentylenetetrazole
使用GABA药效团和相应的杂环部分,将新型的4-GABA-3-硝基香豆素,1-硫代香豆素,喹诺酮-2-酮及其衍生物设计为潜在的抗惊厥药。合成了该组中的许多化合物,并在最大电击惊厥(MES)测试中以及在小鼠皮下戊四氮(scPTZ)引起的原发性惊厥模型中进行了研究。在MES测试中发现活性最高的化合物是1a(N-(3-硝基香豆素-4-基)-4-氨基丁酸),剂量范围为60-80 mg / kg,可增加存活动物的数量与对照组的60%相比,后者的存活率为10%。化合物1d(N-(3,6-二硝基香豆素-4-基)-4-氨基丁酸甲酯)剂量为10–40 mg / kg和3a(N-(3-硝基-2-氧代-1,2-二氢喹啉) 12.5 mg / kg剂量的-4-基)-4-氨基丁酸甲酯)在scPTZ测试中具有最明显的抗惊厥作用。